Joan W. Miller, MD, Chair of Harvard Ophthalmology and the David Glendenning Cogan Professor of Ophthalmology at Harvard Medical School, is featured on the World Medical Innovation Forum’s 2023 “Disruptive Dozen” list of 12 emerging technologies with the greatest potential to impact health care in the next several years.... Read more about Joan W. Miller, MD, Featured on World Medical Innovation Forum Disruptive Dozen List

The Atlantic Coast Retina Club (ACRC) Meeting and Macula 2023 returned to Boston last week for three days of events at Mass Eye and Ear and the Seaport Hotel. More than 300 people attended from across the country.... Read more about Atlantic Coast Retina Club/Macula 2023 a Great Success

Wentworth-Douglass Hospital teamed up with retina specialists at Mass Eye and Ear to launch a new Retinopathy of Prematurity (ROP) program that allows infants to remain local while receiving specialized eye exams.... Read more about Mass Eye and Ear Retina Team Launches ROP Program with Wentworth-Douglass Hospital

This year’s Iraty Award for Research in Retinal Diseases honors Leo A. Kim, MD, PhD, an Associate Professor of Ophthalmology at Harvard Medical School (HMS) and the Monte J. Wallace Ophthalmology Chair in Retina at Mass Eye and Ear.... Read more about Leo A. Kim, MD, PhD, Receives 2022 Iraty Award for Research in Retinal Diseases

Three talented vitreoretinal surgery fellows at Mass Eye and Ear were recognized with the following awards and fellowships.... Read more about 2021 Mass Eye and Ear Retina Awards and Fellowships

Cris Jacoba, MD, and Konstantina Sampani, MD, both fellows at the Beetham Eye Institute at Joslin Diabetes Center, placed first and second, respectively, in the New England Ophthalmological Society annual Hecht poster contest for residents and fellows.... Read more about Beetham Eye Institute Fellows Recognized with Awards and Fellowships

Ivana K. Kim, MD, Associate Professor of Ophthalmology at Harvard Medical School and Director of the Macular Degeneration Unit and Co-Director of the Ocular Melanoma Center, was selected to present the Paul Henkind Memorial Lecture at the Macula Society 2022 annual meeting in June.... Read more about Ivana Kim, MD, to Present Paul Henkind Memorial Lecture

Leo A. Kim, MD, PhD, a clinician scientist with surgical expertise and an innovator in the treatment of retinal diseases associated with neovascularization and fibrosis and an Associate Professor of Ophthalmology at Harvard Medical School, will serve as the next incumbent of the Monte J. Wallace Ophthalmology Chair in Retina at Mass Eye and Ear, effective December 1, 2021.... Read more about Leo A. Kim, MD, PhD, Next Incumbent of the Monte J. Wallace Ophthalmology Chair in Retina at Mass Eye and Ear

This year's Iraty Award for Research in Retinal Diseases honors Petr Baranov, PhD, a scientist at Schepens Eye Research Institute of Mass. Eye and Ear and Assistant Professor of Ophthalmology...

A recent meta-analysis, led by Deeba Husain, MD, suggests that AMD patients present distinct plasma metabolomic profiles, which vary with disease severity. After analyzing blood samples of their 491 patients from two cohorts–one in Boston and one in Coimbra, Portugal–they found that metabolites differed significantly between AMD patients as compared to controls, and with various stages of the disease.... Read more about Researchers Identify Metabolomics as a Potential Tool to Improve Diagnostic and Prognostic Information on AMD

The Atlantic Coast Retina Club (ACRC) Meeting and Macula 2019 Conference was held at Mass. Eye and Ear and the Seaport Hotel on January 10-12.... Read more about ACRC/Macula 2019 a Success

A study led by Eleftherios Paschalis, PhD, describes a mechanism by which patients with acute ocular injuries become susceptible to progressive neurodegeneration long after the injury has taken place.... Read more about Neuroglial Remodeling After Injury May Contribute to Retinal Degeneration

Pictured above: Retinal microglia (green) and the retinal vasculature (magenta). Photo credit: Dong-Ho Park, M.D., Connor Lab.

A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment.... Read more about Microglia protect sensory cells needed for vision after retinal detachment

Boston, Mass. — Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval gene therapy for patients with a form of inherited blindness. The occasion marks the beginning of a new era in medicine, as it is the first time any FDA-approved gene therapy has been given to a patient for any inherited disease.

The treatment, commercially identified as Luxturna, was developed by Spark Therapeutics and ...